Shenyang Neusoft Zhirui Radiotherapy Technology

Shenyang Neusoft Zhirui Radiotherapy Technology, also known as IntelliRay, develops and researches oncology treatment equipment. The company was founded in 2018 and is headquartered in Shenyang, China. IntelliRay is a subsidiary of Neusoft Medical Systems, which in turn is a subsidiary of Neusoft Corporation, China's largest IT solutions and services provider. The parent company, Neusoft, was founded in 1991 by professors from Northeastern University and was the first listed software company in China.

The company focuses on creating accurate and intelligent radiotherapy technologies to improve the effectiveness of cancer treatments. Its product line includes the NeuRT Aurora, a device that provides diagnostic-grade image-guided precise irradiation, and NeuOIS, a cloud-based remote radiation therapy platform. IntelliRay's solutions are part of a broader portfolio from Neusoft Medical that includes CT scanners, MRI systems, linear accelerators, and treatment planning software. The technology incorporates features like the Collapsed Cone Convolution Superposition (CCCS) algorithm, considered a highly accurate 3D dose calculation model, and powerful 3D visualization tools.

IntelliRay operates as a venture capital-backed, privately held company. It has successfully raised capital through multiple funding rounds, including a Series C round in June 2024 that raised CNY 100 million, led by Neusoft and Lucky Capital. Other notable investors include In Capital, Lenovo Capital and Incubator Group, 6 Dimensions Capital, and Ivy Capital.

Keywords: radiotherapy technology, oncology treatment equipment, medical devices, cancer treatment, linear accelerator, treatment planning system, image-guided radiotherapy, NeuRT Aurora, Neusoft Medical, radiation therapy, intelligent healthcare, medical imaging, oncology solutions, CCCS algorithm, cloud radiotherapy, precision oncology